Robotic adrenalectomy with imaging to guide dissection using a dye
Official title: Randomized Prospective Study of Robotic Adrenalectomy With Versus Without Indocyanine Green Fluorescence Imaging
Run by The Cleveland Clinic · NCT07813247 · Data updated 2026-11-12
A randomized comparison tests whether adding indocyanine green (ICG) imaging during robotic adrenalectomy helps surgeons find the adrenal gland and perform the operation.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 55 (estimated) |
| Sponsor | The Cleveland Clinic Academic / other |
| Locations | 1 site (Cleveland, Ohio) |
| Status | Recruiting |
| Started | July 31, 2026 |
| Main results expected | December 30, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | September 10, 2026 |
| Trial ID | NCT07813247 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adult patients scheduled for robotic adrenalectomy who have no iodine allergy.
✕Probably not a fit
Patients who are not iodine-allergic or whose anatomy does not benefit from fluorescence may see no advantage.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective randomized study compares robotic adrenalectomy performed with ICG fluorescence imaging to robotic adrenalectomy without ICG. ICG imaging highlights perfused tissues and may ease identification of the adrenal gland, potentially improving precision and reducing blood loss. Traditional intraoperative ultrasound can be limited by air gaps and interruptions; ICG offers a real-time, continuous imaging modality. The study focuses on intraoperative and perioperative outcomes to see if ICG improves the safety and efficiency of the procedure.
Why it matters
Potential benefit: If successful, ICG imaging could make robotic adrenalectomy safer and quicker for patients.
How similar studies have gone: Prior experiences and non-randomized studies suggest feasibility and safety of ICG in robotic adrenalectomy, but randomized evidence is not yet established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * adult patients scheduled for robotic adrenalectomy Exclusion Criteria: * patients scheduled for laparoscopic or open adrenalectomy or with an iodine allergy
Where it's running
-
Cleveland Clinic Foundation
Cleveland, Ohio, United States Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tirzepatide after adrenalectomy for MACS
This study tests whether adding tirzepatide after adrenalectomy helps control blood pressure and improve metabolic health in adults with mild autonomous cortisol secretion.
-
Radiofrequency Ablation vs Adrenalectomy for unilateral aldosterone-producing adenoma with hypertension
This study tests whether radiofrequency ablation can match adrenalectomy in treating unilateral aldosterone-producing adenoma causing high blood pressure.
-
Adrenal vein sampling in China
This project tests whether different adrenal venous sampling techniques and AVS-guided management help people with primary aldosteronism get better long-term blood pressure and hormone results.
-
Using Gallium-68 Pentixafor PET-CT to improve surgery outcomes in primary aldosteronism
This trial will test whether adding gallium-68 pentixafor PET/CT to standard adrenal venous sampling helps people with primary aldosteronism have better results from adrenal surgery.
-
Comparing laparoscopic and robotic adrenal surgery
This study is testing whether laparoscopic or robotic surgery works better for removing adrenal tumors to help improve patient care and surgical practices.
-
Omitting preoperative alpha-blockade for normotensive pheochromocytoma
This study is testing whether skipping a common medication before surgery can help patients with certain tumors avoid low blood pressure during and after their operation without putting them at risk.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.